Morpholino

MO2-rps19

ID
ZDB-MRPHLNO-091103-1
Name
MO2-rps19
Previous Names
  • rps19 splicing MO
Target
Sequence
5' - GCTTCCCCGACCTTTCAAAAGACAA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genome Build: GRCz11Chromosome: 16
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-rps19
Expressed Gene Anatomy Figures
ada Fig. 4 from Danilova et al., 2008
baxa Fig. 4 from Danilova et al., 2008
c6.1 Fig. 5 from Danilova et al., 2018
cdkn1a Fig. 4 from Danilova et al., 2008
cfb Fig. 5 from Danilova et al., 2018
cfh Fig. 5 from Danilova et al., 2018
fn1b Fig. 3 from Danilova et al., 2018
fsta Fig. 4 from Danilova et al., 2018
gata2a Fig. 5 from Danilova et al., 2008
gsc Fig. 5 from Danilova et al., 2008
hbae1.1 Fig. 3 from Danilova et al., 2008
ifih1 Fig. 2 from Danilova et al., 2018
il6 Fig. 3 from Danilova et al., 2018
inha Fig. 4 from Danilova et al., 2018
ins Fig. 2 from Danilova et al., 2008
irf3 Fig. 1 from Danilova et al., 2018
irf7 Fig. 1 from Danilova et al., 2018
isg15 Fig. 1 from Danilova et al., 2018
lft2 Fig. 2 from Danilova et al., 2008
mmp9 Fig. 3 from Danilova et al., 2018
ptgs2a Fig. 3 from Danilova et al., 2018
smad7 Fig. 4 from Danilova et al., 2018
socs3a Fig. 1 from Danilova et al., 2018
socs3b Fig. 1 from Danilova et al., 2018
stat1b Fig. 1 from Danilova et al., 2018
tlr1 Fig. 1Fig. 2 from Danilova et al., 2018
tlr3 Fig. 2 from Danilova et al., 2018
tlr9 Fig. 2 from Danilova et al., 2018
tnfa Fig. 3 from Danilova et al., 2018
tp53 Fig. 4 from Danilova et al., 2008
tp63 Fig. 4Fig. 5 from Danilova et al., 2008
tp73 Fig. 4 from Danilova et al., 2008
Phenotype
Phenotype resulting from MO2-rps19
Phenotype Fish Figures
blood apoptotic process increased process quality, abnormal WT + MO2-rps19 Fig. 6 with image from Danilova et al., 2014
brain necrotic, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
cranial cartilage malformed, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
digestive system position, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
embryo development arrested, abnormal AB + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
erythrocyte development disrupted, abnormal WT + MO2-rps19 Fig. 3 from Danilova et al., 2008
erythrocyte differentiation decreased occurrence, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
eye aplastic, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
eye decreased size, abnormal WT + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
Fig. 2 from Danilova et al., 2008
eye hypoplastic, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
forebrain aplastic, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
forebrain decreased size, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
head decreased size, abnormal WT + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
Fig. 2 from Danilova et al., 2008
head apoptotic process increased process quality, abnormal WT + MO2-rps19 Fig. 6 with image from Danilova et al., 2014
heart malformed, abnormal WT + MO2-rps19 Fig. 3 from Wilkes et al., 2020
heart primordium position, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
intermediate cell mass of mesoderm erythroblast increased amount, abnormal WT + MO2-rps19 Fig. 3 from Danilova et al., 2008
midbrain hindbrain boundary malformed, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
nucleate erythrocyte decreased amount, abnormal WT + MO2-rps19 Fig. 3 with image from Danilova et al., 2014
Fig. 3 from Danilova et al., 2008
optic primordium decreased size, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
post-vent region kinked, abnormal AB + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
trunk curved, abnormal AB + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
whole organism apoptotic, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
whole organism inha expression decreased amount, abnormal AB + MO2-rps19 Fig. 4 from Danilova et al., 2018
whole organism decreased length, abnormal AB + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
whole organism decreased life span, abnormal AB + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
whole organism decreased size, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
whole organism ptgs2a expression increased amount, abnormal AB + MO2-rps19 Fig. 3 from Danilova et al., 2018
whole organism cfb expression increased amount, abnormal AB + MO2-rps19 Fig. 5 from Danilova et al., 2018
whole organism cfh expression increased amount, abnormal AB + MO2-rps19 Fig. 5 from Danilova et al., 2018
whole organism il6 expression increased amount, abnormal AB + MO2-rps19 Fig. 3 from Danilova et al., 2018
whole organism tlr3 expression increased amount, abnormal AB + MO2-rps19 Fig. 2 from Danilova et al., 2018
whole organism tlr1 expression increased amount, abnormal AB + MO2-rps19 Fig. 1Fig. 2 from Danilova et al., 2018
whole organism tlr9 expression increased amount, abnormal AB + MO2-rps19 Fig. 2 from Danilova et al., 2018
whole organism ifih1 expression increased amount, abnormal AB + MO2-rps19 Fig. 2 from Danilova et al., 2018
whole organism stat1b expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism isg15 expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism fsta expression increased amount, abnormal AB + MO2-rps19 Fig. 4 from Danilova et al., 2018
whole organism tnfa expression increased amount, abnormal AB + MO2-rps19 Fig. 3 from Danilova et al., 2018
whole organism socs3b expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism mmp9 expression increased amount, abnormal AB + MO2-rps19 Fig. 3 from Danilova et al., 2018
whole organism socs3a expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism irf7 expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism irf3 expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism c6.1 expression increased amount, abnormal AB + MO2-rps19 Fig. 5 from Danilova et al., 2018
whole organism fn1b expression increased amount, abnormal AB + MO2-rps19 Fig. 3 from Danilova et al., 2018
whole organism smad7 expression increased amount, abnormal AB + MO2-rps19 Fig. 4 from Danilova et al., 2018
whole organism morphology, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
whole organism anterior-posterior axis curved, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
whole organism anterior-posterior axis kinked, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
whole organism hemoglobin decreased amount, abnormal WT + MO2-rps19 Fig. 3 from Wilkes et al., 2020
whole organism ribosome decreased amount, abnormal WT + MO2-rps19 Fig. 1 from Danilova et al., 2008
Phenotype of all Fish created by or utilizing MO2-rps19
Phenotype Fish Conditions Figures
whole organism irf7 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
embryo development arrested, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
whole organism ptgs2a expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2018
whole organism tlr1 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1Fig. 2 from Danilova et al., 2018
whole organism isg15 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
whole organism stat1b expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
whole organism cfb expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 5 from Danilova et al., 2018
whole organism mmp9 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2018
whole organism decreased length, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
whole organism tlr9 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2018
eye decreased size, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
post-vent region kinked, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
whole organism fn1b expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2018
whole organism decreased life span, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
whole organism socs3b expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
trunk curved, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
whole organism cfh expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 5 from Danilova et al., 2018
whole organism il6 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2018
whole organism inha expression decreased amount, abnormal AB + MO2-rps19 standard conditions Fig. 4 from Danilova et al., 2018
whole organism ifih1 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2018
whole organism socs3a expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
whole organism smad7 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 4 from Danilova et al., 2018
whole organism c6.1 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 5 from Danilova et al., 2018
whole organism fsta expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 4 from Danilova et al., 2018
whole organism tlr3 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2018
whole organism irf3 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
whole organism tnfa expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2018
head decreased size, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
nucleate erythrocyte decreased amount, abnormal WT + MO2-rps19 standard conditions Fig. 3 with image from Danilova et al., 2014
Fig. 3 from Danilova et al., 2008
whole organism apoptotic, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
forebrain aplastic, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
eye aplastic, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
heart malformed, abnormal WT + MO2-rps19 chemical treatment by environment: metformin Fig. 3 from Wilkes et al., 2020
whole organism decreased size, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
heart primordium position, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
eye decreased size, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
whole organism anterior-posterior axis kinked, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
eye hypoplastic, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
erythrocyte differentiation decreased occurrence, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
midbrain hindbrain boundary malformed, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
blood apoptotic process increased process quality, abnormal WT + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2014
forebrain decreased size, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
whole organism morphology, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
brain necrotic, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
digestive system position, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
whole organism hemoglobin amount, ameliorated WT + MO2-rps19 chemical treatment by environment: metformin Fig. 3 from Wilkes et al., 2020
erythrocyte development disrupted, abnormal WT + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2008
optic primordium decreased size, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
whole organism anterior-posterior axis curved, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
head apoptotic process increased process quality, abnormal WT + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2014
whole organism ribosome decreased amount, abnormal WT + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2008
heart malformed, abnormal WT + MO2-rps19 standard conditions Fig. 3 from Wilkes et al., 2020
head decreased size, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
cranial cartilage malformed, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
whole organism hemoglobin decreased amount, abnormal WT + MO2-rps19 standard conditions Fig. 3 from Wilkes et al., 2020
intermediate cell mass of mesoderm erythroblast increased amount, abnormal WT + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2008
whole organism irf7 expression increased amount, abnormal tp53zdf1/zdf1 + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
whole organism c6.1 expression increased amount, abnormal tp53zdf1/zdf1 + MO2-rps19 standard conditions Fig. 5 from Danilova et al., 2018
whole organism tlr3 expression increased amount, abnormal tp53zdf1/zdf1 + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2018
Citations